Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shenkefu Capsule in Chronic Kidney Disease (Phase II)
CTR20191029Phase 2Completed
- Sponsor
- Chengdu Nanshan Pharmaceutical
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Shenkefu in chronic kidney disease (CKD), sponsored by Chengdu Nanshan Pharmaceutical. Started Jun 2019; status: completed.
02
Drugs
Shenkefu
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on CTR20191029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20191029.